Saturday 17 October 2026 Export MNPR’s income statement to Excel — free account

Monopar Therapeutics Inc.

In the quarter to June 2026, EPS fell 77.1% and free cash flow fell 201.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

69.27 2.53 −3.52%

Follow MNPR

Alert me

Market cap: $481.9M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(19.50%)	(15.86%)	(14.22%)	(26.54%)	+8 more TTM periods Free account
ROA Full definition →	(18.90%)	(15.52%)	(13.65%)	(25.88%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(13.65%)	(11.08%)	(9.96%)	(13.74%)
Free Cash Flow per Share Full definition →	(1.43)	(1.17)	(1.65)	(1.52)
Free Cash Flow Full definition →	(12.18)	(10.01)	(12.20)	(10.83)
Other line items
Cash ROIC Full definition →	(4.59%)	(3.67%)	(4.39%)	(3.80%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.68	0.67	0.89	0.56
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	—
Capex/Depreciation Full definition →	0.00	0.00	0.00	—
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(1.43)	(1.17)	(1.65)	(1.52)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly